Pancreatic Cancer Research

ResearcherNanjing General Hospital of Nanjing Military CommandNo recent work listed

Guangming Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0303-1489; OpenAlex author ID A5101877445. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. Sequential therapy for pancreatic cancer by losartan- and gemcitabine-loaded magnetic mesoporous spheres. Last author DOI 10.1039/c9ra02180a↗
  2. A c(RGDfE) conjugated multi-functional nanomedicine delivery system for targeted pancreatic cancer therapy. Last author DOI 10.1039/c4tb01402b↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanjun Li · 2 shared papers, 2015–2019 · strength 0.15
  2. Ying Liu · 1 shared paper, 2019 · strength 0.10
  3. Dong‐Hyun Kim · 1 shared paper, 2015 · strength 0.05
  4. Andrew C. Larson · 1 shared paper, 2015 · strength 0.05
  5. Yang Guo · 1 shared paper, 2015 · strength 0.05
  6. Jing Sun · 1 shared paper, 2015 · strength 0.05
  7. Zhuoli Zhang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.